Loading...
| A03410 | Pages: NA | May 2022 | 7846 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Rapid Diagnostics Market
Request Now !Rapid diagnostic test (RDT) is essentially utilized in preliminary or emergency medical screening along with medical facilities that have limited resources. RDTs enable point-of-care testing in primary care by quick and easy operations. Rapid diagnostics is incorporated in several conventional diagnostics tests such as rapid antibody tests including rapid HIV test, rapid plasma regain, and rapid antigen tests that include rapid influenza diagnostic test & malaria antigen detection tests among others.
Rapid diagnostic tests are highly adopted for diagnosis, patient management, epidemiology, and screening. The major factors that fuel the growth of the market are increase in the demand for rapid diagnostic tests in decentralized settings along with rising awareness regarding early diagnosis among people. In addition, the escalating need for inexpensive diagnostic testing coupled with accuracy raises the market growth. However, lack of awareness regarding newer rapid diagnostic tests available in the market restrains the growth of the rapid diagnostics market. Moreover, the rising demand for bedside diagnostic testing will offer profitable opportunities for the growth of the rapid diagnostics market.
The report segments the market on the basis of product, application, and region. Based on product, the market is divided into over-the-counter (OTC) rapid diagnostics test and professional rapid diagnostics test. Based on application, the market is classified into blood glucose rapid diagnostics, infectious diseases rapid diagnostics, cardiometabolic rapid diagnostics, coagulation rapid diagnostics, pregnancy & fertility rapid diagnostics, fecal occult blood rapid diagnostics, and toxicology rapid diagnostics. Based on region, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players profiled in this market are Abaxis, Becton, Dickinson and Company, Bio-Rad Laboratories, Accriva Diagnostics, ACON Laboratories, Inc., Hologic, Inc., Abbott Laboratories, Roche Diagnostics, Bayer HealthCare Pharmaceuticals LLC, and Cepheid Inc.
Key Benefits
Key Market Segments
| Segments | Sub-segments |
|---|---|
| By Product |
|
| By Application |
|
| By Region |
|
Key Market Players
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 GLOBAL RAPID DIAGNOSTICS MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. OVER-THE-COUNTER (OTC) RAPID DIAGNOSTICS TEST
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. PROFESSIONAL RAPID DIAGNOSTICS TEST
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
CHAPTER 5 GLOBAL RAPID DIAGNOSTICS MARKET, BY APPLICATION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. BLOOD GLUCOSE RAPID DIAGNOSTICS
5.2.1. Market size and forecast
5.3. INFECTIOUS DISEASES RAPID DIAGNOSTICS
5.3.1. Market size and forecast
5.4. CARDIOMETABOLIC RAPID DIAGNOSTICS
5.4.1. Market size and forecast
5.5. COAGULATION RAPID DIAGNOSTICS
5.5.1. Market size and forecast
5.6. PREGNANCY & FERTILITY RAPID DIAGNOSTICS
5.6.1. Market size and forecast
5.47 FECAL OCCULT BLOOD RAPID DIAGNOSTICS
5.7.1. Market size and forecast
5.8. TOXICOLOGY RAPID DIAGNOSTICS
5.8.1. Market size and forecast
CHAPTER 6 GLOBAL RAPID DIAGNOSTICS MARKET, BY REGION
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast
6.2.4. North America Rapid Diagnostics Market by Type
6.2.5. North America Rapid Diagnostics Market by Application
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast
6.3.4. Europe Rapid Diagnostics Market by Type
6.3.5. Europe Rapid Diagnostics Market by Application
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. Rest of Asia-Pacific market size and forecast
6.4.4. Asia-Pacific Rapid Diagnostics Market by Type
6.4.5. Asia-Pacific Rapid Diagnostics Market by Application
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.3.1. Brazil market size and forecast
6.5.3.2. Saudi Arabia market size and forecast
6.5.3.3. Argentina market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast
6.5.4. LAMEA Rapid Diagnostics Market by Type
6.5.5. LAMEA Rapid Diagnostics Market by Application
CHAPTER 7 COMPANY PROFILES
7.1. ABAXIS
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. BECTON DICKINSON CO.
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. BIO-RAD LABORATORIES
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. ACCRIVA DIAGNOSTICS
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. ACON LABORATORIES, INC.
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. HOLOGIC, INC.
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. ABBOTT LABORATORIES
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. ROCHE DIAGNOSTICS
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. BAYER HEALTHCARE PHARMACEUTICALS LLC
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. CEPHEID INC.
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
